Markets News
Latest stock market news and real-time market analysis. Track S&P 500, Nasdaq, and Dow Jones movements, sector rotations, and breaking market events.
LightPath Technologies Soars to 52-Week High on Defense Optics Demand
LightPath Technologies shares surged 10% to a 52-week high of $16.09 on robust defense optics orders and a $97.8 million backlog, with Q2 revenue soaring 120%.
Plug Power's Louisiana JV Plant Reaches 90% Availability Amid Cash Flow Focus
Plug Power's Louisiana hydrogen plant achieved 90% availability in Q1, producing 448.3 metric tons. Shares fell 1.3% as the company works to improve cash flow.
Liberty Broadband Shares Tumble 26% as Charter's Subscriber Woes Hit Merger Value
Liberty Broadband shares plunged 26% Friday, mirroring Charter Communications' decline after the cable operator lost 120,000 internet subscribers in Q1, exceeding forecasts and pressuring the pending all-stock merger.
Eminence Capital to Close After 27 Years, Return $5.9 Billion
Eminence Capital, founded by Ricky Sandler, is closing after 27 years, returning $5.9 billion to investors by late June amid poor returns and rising expenses.
Hims & Hers Surges on JPMorgan Upgrade and GLP-1 Expansion
Hims & Hers stock jumped 9% after JPMorgan gave an overweight rating and $35 target. The company now offers Eli Lilly's Zepbound and Foundayo through LillyDirect.
CoreWeave CEO Cashes Out $35.8M Amid AI Cloud Rally
CoreWeave CEO Michael Intrator sold $35.8 million in shares this week, while the company announced major customer deals and debt financing.
StoneCo Shares Tumble 16% After Ex-Dividend Date for $2.53 Special Payout
StoneCo (STNE) shares dropped 16.3% to $12.18 on Friday after trading ex-dividend for a $2.53 special cash dividend, totaling R$3.08 billion. The payout follows the sale of Linx and 2025 earnings growth.
Nasdaq Hits Record as Intel AI Outlook Fuels Chip Rally, Dow Dips
The Nasdaq hit a new intraday high Friday as Intel's strong Q2 outlook sparked a broad chip rally, while the Dow slipped. Consumer sentiment hit a record low, keeping inflation worries front and center.
Lilly's Oral Obesity Drug Foundayo Trails Novo Nordisk's Wegovy in Early Prescription Data
Eli Lilly's Foundayo prescriptions hit 3,707 in week two, well behind Novo Nordisk's Wegovy. Lilly shares dropped 4%, while Novo gained 6%. Analysts advise caution on early figures.
Cheetah Net Soars on Acquisition Deal, Heavy Trading Volume
Cheetah Net shares jumped on heavy volume after agreeing to buy Super International Trading for $4.98M in cash, with a $10M annual revenue target.
FreeCast Soars on DIRECTV Multifamily Deal, Financing Risks Remain
FreeCast shares jumped 23.8% on a DIRECTV multifamily deal. Maxim Group initiated with Buy and $6 target. Dilution risks persist per SEC filings.
Novo Nordisk Wegovy Pill Prescriptions Surge Past Eli Lilly's Foundayo in Early Launch Race
Novo Nordisk's Wegovy pill recorded 18,410 U.S. prescriptions in its second week, far outpacing Eli Lilly's Foundayo at 3,707, according to IQVIA data. Novo shares rose, Lilly fell.